Skip to main content

Advertisement

Log in

Cardiac sympathetic denervation in Parkinson’s disease patients with SWEDDs

  • Original Article
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

Dopamine transporter scans of some patients who have been clinically diagnosed with Parkinson’s disease (PD) fail to reveal abnormal dopaminergic functioning and are referred to as scans without evidence of dopaminergic deficits (SWEDDs). In this study, we investigated the differences between SWEDDs patients and PD patients using 123I-metaiodobenzylguanidine (MIBG) scans. This study enrolled 20 patients with SWEDDs, 30 patients with early PD and 50 healthy controls. Cardiac 123I-MIBG scans were performed on all subjects, and parameters including the early and delayed heart-to-mediastinum ratios (H/M) and the washout rate were compared among the three groups. The mean delayed H/M ratio in the PD group (mean ± standard deviation, 1.45 ± 0.23) was the lowest of the three groups, and the scans in the group without evidence of dopaminergic deficits exhibited a lower mean delayed H/M ratio (2.15 ± 0.48) than the control group (2.56 ± 0.55) (p < 0.05). The intermediate status of cardiac MIBG uptake in the SWEDDs patients in our study may have been due to the heterogeneity of the SWEDDs patients; some of these patients had Parkinsonism with unknown characteristics, some may have had early PD with false-negative dopamine transporter imaging, and some have had primary dystonia that was misdiagnosed as PD. These uncharacterised SWEDDs patients accounted for a larger proportion of the heterogeneous SWEDDs than observed in previous studies, but our results suggest that cardiac 123I-MIBG scans may help to differentiate patients with SWEDDs from patients with PD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Spiegel J, Möllers M-O, Jost WH, Fuss G, Samnick S, Dillmann U, Becker G, Kirsch C-M (2005) FP-CIT and MIBG scintigraphy in early Parkinson’s disease. Mov Disord 20(5):552–561

    Article  PubMed  Google Scholar 

  2. Rascol O, Schelosky L (2009) 123I-metaiodobenzylguanidine scintigraphy in Parkinson’s disease and related disorders. Mov Disord 24(S2):S732–S741

    Article  PubMed  Google Scholar 

  3. Winogrodzka A, Bergmans P, Booij J, van Royen EA, Stoof JC, Wolters EC (2003) [123I]β-CIT SPECT is a useful method for monitoring dopaminergic degeneration in early stage Parkinson’s disease. J Neurol Neurosurg Psychiatry 74(3):294–298

    Article  PubMed  CAS  Google Scholar 

  4. Marek K, Seibyl J, Parkinson Study Group (2008) Beta-CIT scans without evidence of dopaminergic deficit(SWEDD) in the ELLDOPA-CIT and CALM-CIT studies: long-term imaging assessment. Neurology 60(Suppl 1):A293

    Google Scholar 

  5. Whone AL, Watts RL, Stoessl AJ, Davis M, Reske S, Nahmias C, Lang AE, Rascol O, Ribeiro MJ, Remy P, Poewe WH, Hauser RA, Brooks DJ (2003) Slower progression of Parkinson’s disease with ropinirole versus levodopa: The REAL-PET study. Ann Neurol 54(1):93–101

    Article  PubMed  CAS  Google Scholar 

  6. Schneider SA, Edwards MJ, Mir P, Cordivari C, Hooker J, Dickson J, Quinn N, Bhatia KP (2007) Patients with adult-onset dystonic tremor resembling Parkinsonian tremor have scans without evidence of dopaminergic deficit (SWEDDs). Mov Disord 22(15):2210–2215

    Article  PubMed  Google Scholar 

  7. Schwingenschuh P, Ruge D, Edwards MJ, Terranova C, Katschnig P, Carrillo F, Silveira-Moriyama L, Schneider SA, Kägi G, Palomar FJ, Talelli P, Dickson J, Lees AJ, Quinn N, Mir P, Rothwell JC, Bhatia KP (2010) Distinguishing SWEDDs patients with asymmetric resting tremor from Parkinson’s disease: a clinical and electrophysiological study. Mov Disord 25(5):560–569

    Article  PubMed  Google Scholar 

  8. Druschky A, Hilz MJ, Platsch G, Radespiel-Tröger M, Druschky K, Kuwert T, Neundörfer B (2000) Differentiation of Parkinson’s disease and multiple system atrophy in early disease stages by means of I-123-MIBG-SPECT. J Neurol Sci 175(1):3–12

    Article  PubMed  CAS  Google Scholar 

  9. Orimo S, Takahashi A, Uchihara T, Mori F, Kakita A, Wakabayashi K, Takahashi H (2007) Degeneration of cardiac sympathetic nerve begins in the early disease process of Parkinson’s disease. Brain Pathol 17(1):24–30

    Article  PubMed  CAS  Google Scholar 

  10. Gasser T, Schwarz J, Arnold G, Trenkwalder C, Oertel WH (1992) Apomorphine test for dopaminergic responsiveness in patients with previously untreated Parkinson’s disease. Arch Neurol 49(11):1131–1134

    Article  PubMed  CAS  Google Scholar 

  11. Park HK, Kim JS, Im KC, Oh SJ, Kim MJ, Lee J-H, Chung SJ, Lee MC (2009) Functional brain imaging in pure akinesia with gait freezing: [18F] FDG PET and [18F] FP-CIT PET analyses. Mov Disord 24(2):237–245

    Article  PubMed  Google Scholar 

  12. Mozley PD, Kim H-J, Gur RC, Tatsch K, Muenz LR, McElgin WT, Kung M-P, Mu M, Myers AM, Kung HF (1996) Iodine-123-IPT SPECT imaging of CNS dopamine transporters: nonlinear effects of normal aging on striatal uptake values. J Nucl Med 37(12):1965–1970

    PubMed  CAS  Google Scholar 

  13. Bain PG (2009) Dystonic tremor presenting as Parkinsonism: long-term follow-up of SWEDDs. Neurology 72(16):1443–1445

    Article  PubMed  Google Scholar 

  14. Mian OS, Schneider SA, Schwingenschuh P, Bhatia KP, Day BL (2011) Gait in SWEDDs patients: comparison with Parkinson’s disease patients and healthy controls. Mov Disord 26(7):1266–1273

    Article  PubMed  Google Scholar 

  15. Silveira-Moriyama L, Schwingenschuh P, O’Donnell A, Schneider SA, Mir P, Carrillo F, Terranova C, Petrie A, Grosset DG, Quinn NP, Bhatia KP, Lees AJ (2009) Olfaction in patients with suspected Parkinsonism and scans without evidence of dopaminergic deficit (SWEDDs). J Neurol Neurosurg Psychiatry 80(7):744–748

    Article  PubMed  CAS  Google Scholar 

  16. Sixel-Döring F, Liepe K, Mollenhauer B, Trautmann E, Trenkwalder C (2011) The role of 123I-FP-CIT-SPECT in the differential diagnosis of Parkinson and tremor syndromes: a critical assessment of 125 cases. J Neurol 258(12):2147–2154

    Article  PubMed  Google Scholar 

  17. Hall DA, Jennings D, Seibyl J, Tassone F, Marek K (2010) FMR1 gene expansion and scans without evidence of dopaminergic deficits in Parkinsonism patients. Parkinsonism Relat Disord 16(9):608–611

    Article  PubMed  CAS  Google Scholar 

  18. Bajaj NPS, Gontu V, Birchall J, Patterson J, Grosset DG, Lees AJ (2010) Accuracy of clinical diagnosis in tremulous Parkinsonian patients: a blinded video study. J Neurol Neurosurg Psychiatry 81(11):1223–1228

    Article  PubMed  Google Scholar 

  19. Deuschl G, Bain P, Brin M (1998) Consensus statement of the movement disorder society on tremor. Mov Disord 13(S3):2–23

    Article  PubMed  Google Scholar 

  20. Fasano A, Baldari S, Di Giuda D, Paratore R, Piano C, Bentivoglio AR, Girlanda P, Morgante F (2012) Nigro-striatal involvement in primary progressive freezing gait: insights into a heterogeneous pathogenesis. Parkinsonism Relat Disord 18(5):578–584

    Article  PubMed  Google Scholar 

  21. Chung EJ, Lee WY, Yoon WT, Kim BJ, Lee GH (2009) MIBG scintigraphy for differentiating Parkinson’s disease with autonomic dysfunction from Parkinsonism-predominant multiple system atrophy. Mov Disord 24(11):1650–1655

    Article  PubMed  Google Scholar 

  22. Ishibashi K, Saito Y, Murayama S, Kanemaru K, Oda K, Ishiwata K, Mizusawa H, Ishii K (2010) Validation of cardiac 123I-MIBG scintigraphy in patients with Parkinson’s disease who were diagnosed with dopamine PET. Eur J Nucl Med Mol Imaging 37(1):3–11

    Article  PubMed  Google Scholar 

  23. Südmeyer M, Antke C, Zizek T, Beu M, Nikolaus S, Wojtecki L, Schnitzler A, Müller H-W (2011) Diagnostic accuracy of combined FP-CIT, IBZM, and MIBG scintigraphy in the differential diagnosis of degenerative Parkinsonism: a multidimensional statistical approach. J Nucl Med 52(5):733–740

    Article  PubMed  Google Scholar 

  24. Nagayama H, Hamamoto M, Ueda M, Nagashima J, Katayama Y (2005) Reliability of MIBG myocardial scintigraphy in the diagnosis of Parkinson’s disease. J Neurol Neurosurg Psychiatry 76(2):249–251

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by a grant from the Korean Health Technology R&D Project, Ministry for Health Welfare & Family Affairs, Republic of Korea (A101712).

Conflict of interest

The authors have no conflict of interest to disclose.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hee-Tae Kim.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOC 38 kb)

Supplementary material 2 (DOC 60 kb)

Supplementary material 3 (DOC 37 kb)

10072_2012_1244_MOESM4_ESM.jpg

Supplementary Fig. 1 Images of FP-CIT PET/CT at the level of the striatum in a SWEDDs patient. (A): Initial image, (B): Follow-up image after 3 years (JPG 176 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jang, W., Kim, JS., Cho, J.W. et al. Cardiac sympathetic denervation in Parkinson’s disease patients with SWEDDs. Neurol Sci 34, 1375–1382 (2013). https://doi.org/10.1007/s10072-012-1244-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-012-1244-1

Keywords

Navigation